AnaptysBio (ANAB) News Today $21.65 +0.75 (+3.59%) As of 11:00 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ANAB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Guggenheim Boosts AnaptysBio (NASDAQ:ANAB) Price Target to $90.00Guggenheim increased their price objective on AnaptysBio from $54.00 to $90.00 and gave the company a "buy" rating in a research report on Wednesday.May 29 at 10:47 AM | marketbeat.comAnaptysBio, Inc. (NASDAQ:ANAB) Shares Purchased by Two Sigma Investments LPTwo Sigma Investments LP increased its stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 66.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 352,034 shares of the biotechnology company's stock after acquiring an additioMay 29 at 3:58 AM | marketbeat.comAnaptysBio, Inc. (NASDAQ:ANAB) Position Lessened by BNP Paribas Financial MarketsBNP Paribas Financial Markets trimmed its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 65.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,126 shares of the bMay 29 at 3:20 AM | marketbeat.comAnaptysBio (NASDAQ:ANAB) Shares Gap Up Following Analyst UpgradeMay 29 at 1:29 AM | americanbankingnews.comAnaptys to Announce Updated Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025May 27 at 4:15 PM | globenewswire.comTwo Sigma Advisers LP Boosts Position in AnaptysBio, Inc. (NASDAQ:ANAB)Two Sigma Advisers LP raised its stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 58.1% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 293,300 shares of the biotechnology company's stock after purchasing an additional 107,800 shares duringMay 27 at 4:30 AM | marketbeat.comWoodline Partners LP Buys 25,094 Shares of AnaptysBio, Inc. (NASDAQ:ANAB)Woodline Partners LP grew its stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 5.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 485,073 shares of the biotechnology company's stock after purchasingMay 26 at 4:37 AM | marketbeat.comNorthern Trust Corp Boosts Position in AnaptysBio, Inc. (NASDAQ:ANAB)Northern Trust Corp grew its holdings in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 10.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 219,986 shares of the biotechnology company's stock after buying an additional 20,073 shares durMay 26 at 3:02 AM | marketbeat.comAnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by Rafferty Asset Management LLCRafferty Asset Management LLC lifted its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 83.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 70,883 shares of the biotechnologMay 24, 2025 | marketbeat.comFrazier Life Sciences Management L.P. Reduces Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB)Frazier Life Sciences Management L.P. reduced its holdings in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 28.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,573,719 shares of the biotechnology company's stock aftMay 23, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Sells 27,030 Shares of AnaptysBio, Inc. (NASDAQ:ANAB)D. E. Shaw & Co. Inc. lessened its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 12.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 197,107 shares of the biotechnology company's stock after selliMay 22, 2025 | marketbeat.comSoleus Capital Management L.P. Invests $5.48 Million in AnaptysBio, Inc. (NASDAQ:ANAB)Soleus Capital Management L.P. purchased a new stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 414,000 shares of the biotechnology company's stock, valued at approximately $5,481,000. Soleus Capital MMay 21, 2025 | marketbeat.comGraham Capital Management L.P. Purchases Shares of 18,954 AnaptysBio, Inc. (NASDAQ:ANAB)Graham Capital Management L.P. purchased a new stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 18,954 shares of the biotechnology company's stock, valued at approximately $251,000. Graham Capital MMay 21, 2025 | marketbeat.comSanofi Purchases New Stake in AnaptysBio, Inc. (NASDAQ:ANAB)Sanofi purchased a new stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 821,917 shares of the biotechnology company's stock, valued at approximately $10,May 19, 2025 | marketbeat.comAnaptysBio, Inc. (NASDAQ:ANAB) Shares Acquired by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. raised its holdings in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 85.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 85,381 shares of the biotechnology company's stock after buyiMay 19, 2025 | marketbeat.comDimensional Fund Advisors LP Decreases Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB)Dimensional Fund Advisors LP lessened its stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 67.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 31,608 shares of the biotechnology company's stock after selling 64,364 shares during the pMay 19, 2025 | marketbeat.comAnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by Ensign Peak Advisors IncEnsign Peak Advisors Inc grew its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 184.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 215,454 shares of the biotechnology company's stock after purchasing an additional 1May 18, 2025 | marketbeat.comGranahan Investment Management LLC Invests $1.40 Million in AnaptysBio, Inc. (NASDAQ:ANAB)Granahan Investment Management LLC acquired a new stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 106,079 shares of the biotechnology company's stock, valued at approximately $1,404,000.May 13, 2025 | marketbeat.comAnaptysBio, Inc. (ANAB): Among the Unstoppable Growth Stocks to Invest in NowMay 12, 2025 | msn.comWells Fargo & Company MN Trims Stake in AnaptysBio, Inc. (NASDAQ:ANAB)Wells Fargo & Company MN lessened its stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 59.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,120 shares of the biotechnolMay 12, 2025 | marketbeat.comAnaptysBio, Inc. (NASDAQ:ANAB) Receives Consensus Rating of "Moderate Buy" from AnalystsAnaptysBio, Inc. (NASDAQ:ANAB - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the ten analysts that are covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issuedMay 12, 2025 | marketbeat.comBridgefront Capital LLC Makes New $252,000 Investment in AnaptysBio, Inc. (NASDAQ:ANAB)Bridgefront Capital LLC acquired a new position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 19,011 shares of the biotechnology company's stockMay 11, 2025 | marketbeat.comQ2 Earnings Forecast for AnaptysBio Issued By HC WainwrightAnaptysBio, Inc. (NASDAQ:ANAB - Free Report) - Investment analysts at HC Wainwright lowered their Q2 2025 earnings per share estimates for shares of AnaptysBio in a research report issued on Tuesday, May 6th. HC Wainwright analyst E. Bodnar now expects that the biotechnology company will earn ($1May 10, 2025 | marketbeat.comLeerink Partnrs Increases Earnings Estimates for AnaptysBioAnaptysBio, Inc. (NASDAQ:ANAB - Free Report) - Analysts at Leerink Partnrs raised their Q2 2025 earnings estimates for AnaptysBio in a research report issued to clients and investors on Tuesday, May 6th. Leerink Partnrs analyst D. Risinger now expects that the biotechnology company will post earnMay 10, 2025 | marketbeat.comFairmount Funds Management LLC Invests $24.05 Million in AnaptysBio, Inc. (NASDAQ:ANAB)Fairmount Funds Management LLC acquired a new stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,816,466 shares of the biotMay 10, 2025 | marketbeat.comAnalysts Are Upgrading AnaptysBio, Inc. (NASDAQ:ANAB) After Its Latest ResultsMay 9, 2025 | finance.yahoo.comAnaptysBio (NASDAQ:ANAB) Price Target Raised to $54.00 at GuggenheimGuggenheim lifted their price objective on AnaptysBio from $52.00 to $54.00 and gave the stock a "buy" rating in a research report on Tuesday.May 8, 2025 | marketbeat.comAnaptysBio (NASDAQ:ANAB) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPSAnaptysBio (NASDAQ:ANAB - Get Free Report) released its quarterly earnings data on Monday. The biotechnology company reported ($1.28) EPS for the quarter, beating the consensus estimate of ($1.30) by $0.02. AnaptysBio had a negative net margin of 289.75% and a negative return on equity of 287.94%.May 7, 2025 | marketbeat.comAnaptysBio First Quarter 2025 Earnings: Beats ExpectationsMay 7, 2025 | finance.yahoo.comBarclays PLC Boosts Stake in AnaptysBio, Inc. (NASDAQ:ANAB)Barclays PLC boosted its holdings in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 88.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 83,567 shares of the biotechnology company'sMay 7, 2025 | marketbeat.comSusquehanna Fundamental Investments LLC Takes $593,000 Position in AnaptysBio, Inc. (NASDAQ:ANAB)Susquehanna Fundamental Investments LLC bought a new stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 44,785 shares of the biotechnology companyMay 6, 2025 | marketbeat.comAnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by Invesco Ltd.Invesco Ltd. reduced its stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 54.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,288 shares of the biotechnology company's stock after selMay 6, 2025 | marketbeat.comAnaptys Announces First Quarter 2025 Financial Results and Provides Business UpdateMay 5, 2025 | globenewswire.comBoxer Capital Management LLC Invests $17.21 Million in AnaptysBio, Inc. (NASDAQ:ANAB)Boxer Capital Management LLC acquired a new stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 1,300,000 shares of the biotechnology company's stock, valued at approximately $17,212,000. AnMay 4, 2025 | marketbeat.comNebula Research & Development LLC Invests $231,000 in AnaptysBio, Inc. (NASDAQ:ANAB)Nebula Research & Development LLC acquired a new position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 17,422 shares of the biotechnology company's stock, valued at approxiMay 4, 2025 | marketbeat.comAnaptysBio (ANAB) to Release Earnings on ThursdayAnaptysBio (NASDAQ:ANAB) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-anaptysbio-inc-stock/)May 3, 2025 | marketbeat.comFirst Light Asset Management LLC Sells 79,249 Shares of AnaptysBio, Inc. (NASDAQ:ANAB)First Light Asset Management LLC lessened its holdings in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 8.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 868,882 shares of the biotechnology compApril 30, 2025 | marketbeat.comAnaptysBio, Inc. (NASDAQ:ANAB) Shares Acquired by Geode Capital Management LLCGeode Capital Management LLC boosted its stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 4.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 486,597 shares of the biotechnology company's stock after acquiring anApril 28, 2025 | marketbeat.comJPMorgan Chase & Co. Raises Holdings in AnaptysBio, Inc. (NASDAQ:ANAB)JPMorgan Chase & Co. lifted its holdings in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 240.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 114,939 shares of the biotechnology company's stock after purchasingApril 28, 2025 | marketbeat.comWells Fargo Sticks to Their Buy Rating for AnaptysBio (ANAB)April 22, 2025 | markets.businessinsider.comAnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by XTX Topco LtdXTX Topco Ltd increased its stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 97.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,013 shares of the biotechnology company's stock after purchasing an additionalApril 22, 2025 | marketbeat.comAnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by Federated Hermes Inc.Federated Hermes Inc. lessened its holdings in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 85.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,184 shares of the biotechnology company's stocApril 19, 2025 | marketbeat.comVanguard Group Inc. Increases Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB)Vanguard Group Inc. grew its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 8.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,843,740 shares of the biotechnology cApril 17, 2025 | marketbeat.comAnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Rating of "Moderate Buy" from BrokeragesShares of AnaptysBio, Inc. (NASDAQ:ANAB - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the ten brokerages that are covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating, five have assigned a buy rating and one hApril 17, 2025 | marketbeat.comTrexquant Investment LP Sells 37,152 Shares of AnaptysBio, Inc. (NASDAQ:ANAB)Trexquant Investment LP decreased its position in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 38.0% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 60,720 shares of the biotechnology company's stock after selling 37,152 shares during the period. TrexApril 14, 2025 | marketbeat.comADAR1 Capital Management LLC Reduces Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB)ADAR1 Capital Management LLC cut its holdings in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 85.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 27,301 shares of the biotechnology company's stock after selling 165,419 shares during the periApril 9, 2025 | marketbeat.comLeerink Partners Sticks to Its Buy Rating for AnaptysBio (ANAB)April 4, 2025 | markets.businessinsider.comAnaptysBio (NASDAQ:ANAB) Trading Up 2.5% - Here's What HappenedAnaptysBio (NASDAQ:ANAB) Trading Up 2.5% - Here's What HappenedMarch 29, 2025 | marketbeat.comLeerink Partners Sticks to Their Buy Rating for AnaptysBio (ANAB)March 28, 2025 | markets.businessinsider.comAnaptysBio could have positive read from J&J abstracts, says GuggenheimMarch 27, 2025 | markets.businessinsider.com Get AnaptysBio News Delivered to You Automatically Sign up to receive the latest news and ratings for ANAB and its competitors with MarketBeat's FREE daily newsletter. Email Address ANAB Media Mentions By Week ANAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANAB News Sentiment▼1.480.87▲Average Medical News Sentiment ANAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANAB Articles This Week▼115▲ANAB Articles Average Week Get AnaptysBio News Delivered to You Automatically Sign up to receive the latest news and ratings for ANAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HUTCHMED News Today Ascentage Pharma Group International News Today Xenon Pharmaceuticals News Today Organon & Co. News Today Amneal Pharmaceuticals News Today ImmunityBio News Today Apellis Pharmaceuticals News Today Mirum Pharmaceuticals News Today Arrowhead Pharmaceuticals News Today Vericel News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANAB) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AnaptysBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AnaptysBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANAB Stock Free ANAB Stock Alerts